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Abstract
Problem: Individuals with substance use disorder (SUD) have disproportionately higher rates of
unintended pregnancy when compared to the general population, estimated to be 85% (Heil et
al., 2011). Not only are poor maternal and fetal outcomes associated with unplanned pregnancies,
but pregnancies in women with SUD are further complicated by additional risks and adverse
outcomes (Black & Day, 2016).
Context: Addiction treatment centers and programs are primed with opportunity to offer family
planning services, when contact with medical providers is increased for substance use treatment.
In response to the opioid crisis and unprecedented rates of unintended pregnancy, this project
was designed to identify, develop, and implement an evidence-based approach to integrate birth
control education and services, emphasizing long-acting reversible contraception (LARC) in
substance use treatment.
Interventions: A two-part interdisciplinary training was designed to include best practice
recommendations regarding LARC utilization and comprehensive contraceptive counseling,
hands-on skills training with vaginal simulators, and subdermal implant training and
certification. In addition, a site feasibility analysis was conducted, to include a client focus
group, staff readiness for change survey, and site assessment, to develop and make
recommendations for a future pilot program for offering birth control services in the on-site
medical clinic.
Measures: A pre/post training assessment was utilized to assess change in provider confidence
and readiness in offering contraceptive counseling and performing LARC procedures in
preparation for service integration on site.
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Results: Through data analysis, results indicated a 33.33% increase in provider comfort with
providing contraceptive counseling, confidence in identifying LARC eligible candidates, and
confidence in counseling clients about the LARC insertion procedure and follow-up. The greatest
changes were seen in provider preparedness in providing counseling regarding LARC safety and
efficacy, with a 44.44% increase and a 57.89% increase in provider comfortability with the
Nexplanon insertion and removal procedure from the pre-training assessments.
Conclusions: Didactic and hands-on training are effective approaches to prepare providers for
service expansion to include contraceptive services at addiction treatment centers. For future
implementation, funding through grants or expanded billing for medical services need to occur.
Keywords: Unintended pregnancy, LARC, contraceptive counseling, substance use
disorder, IUD, intrauterine device, birth control
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Section II: Introduction
Background and Problem Description
Unintended pregnancy is a pervasive, preventable problem throughout the United States.
Some of the highest rates of unplanned pregnancy have been identified in women with a
substance use disorder (SUD). Both SUD and unplanned pregnancies are associated with their
respective individual health challenges and sequelae that are further impacted when combined.
This Doctor of Nursing Practice (DNP) project was designed to address and reduce barriers to
family planning services among women of reproductive age with a SUD. Substance abuse and
the geographical setting will be further discussed to provide a greater understanding of the target
population and existing healthcare disparities.
Substance abuse is defined as “the harmful or hazardous use of psychoactive substances,
including alcohol and illicit drugs” (World Health Organization, 2019, para. 1). Substance abuse
has become a widespread problem, in part due to the opioid crisis. The over prescription of
opioids led to astonishing rates of misuse (21% to 29%) and the development of opioid use
disorder (8% to 12%) in the population (National Institute on Drug Abuse [NIDA], 2019).
Despite the increasing demand for substance abuse treatment, less than 1% are able to receive
treatment (NIDA, 2015). Peak drug usage occurs in the late teens to early twenties (NIDA,
2015). Illicit drug use is higher among males when compared with females, but the gap is
decreasing (National Center for Health Statistics [NCHS], 2017). When identified by race,
substance use rates are highest among White individuals, followed by those identified as two or
more races and then by those who identified as American Indian or Alaskan Native (NCHS,
2017).

LARC APPROPRIATENESS IN SUBSTANCE USE TREATMENT

8

Demographic information regarding the geographical setting were explored to provide a
greater understanding of substance abuse in the context of the greater community as a whole.
Granite Wellness Centers is based in Grass Valley, one of three larger areas that comprise Nevada
County. There are approximately 100,000 residents countywide (Nevada County Public Health
Department, 2016). The median age of the population is 48.5 years, and the largest ethnic group
is Hispanic at 9% (Nevada County Public Health Department, 2016). In 2014, approximately
20% of adults and 8% of children were uninsured (Robert Wood Johnson Foundation, 2015).
Protective factors of the larger community include rates of normal BMI (48.4%), ranking 8th out
of 57 counties in Health Factors and 11th in Health Outcomes (Robert Wood Johnson Foundation,
2015). However, important issues identified by community members involve financial stress,
substance abuse, access to care, and mental health, with nearly 73% of the population noting
substance abuse was an issue and 53% reporting it as a priority concern of the community.
(Nevada County Public Health Department, 2016). When compared to California, Nevada
County has higher rates of substance abuse, which is reflected in higher admission rates to
substance abuse treatment (Shasta County Health and Human Services Agency, 2018).
The Problem: Unintended Pregnancy
The United States has one of the highest rates of unintended pregnancies among
industrialized nations of the world. Approximately 45% or 2.8 million pregnancies per year are
unplanned among women ages 15 years to 44 years (Finer & Zolna, 2016). Rates of unintended
pregnancy in women with SUD are estimated to be nearly double that of the general population
at 85% (Heil et al., 2011). Overall contraceptive use is lower and fewer effective methods are
preferred among women with opioid or other SUDs (Terplan, Hand, Hutchinson, SalisburyAfshar, & Heil, 2015).
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Costs related to unintended pregnancy are derived through the assumption of care
through public funding. The majority (68%) of unplanned births are paid for through public
insurance (Sonfield & Kost, 2015). Including prenatal care, labor and delivery, and postnatal care
for the first year of life, costs are estimated at $12,770 per pregnancy, or $21 billion per year
(Sonfield & Kost, 2015). Further medical costs may develop due to the increase in adverse
maternal and fetal outcomes.
Adverse maternal and fetal outcomes. Unfortunately, poor maternal and fetal outcomes
are associated with unplanned pregnancies. Mothers are more likely to experience a delay in
receiving prenatal care, have an increased risk of depression, be exposed to physical violence
while pregnant, and are less likely to breastfeed (Office of Disease Prevention and Health
Promotion [ODPHP], 2014). Consequences to the neonate include low-birth weight and
increased rates of birth defects (ODPHP, 2014).
Substance use during pregnancy is further associated with an increased risk for placental
abruption, preterm birth, and stillbirth (Black & Day, 2016). Opioid use, in particular, is linked to
a lack of prenatal care, fetal death, preterm labor, and intrauterine passage of meconium, and
neonatal abstinence syndrome (Committee on Obstetric Practice & American Society of
Addiction Medicine, 2017). Neonatal abstinence syndrome refers to a multisystem disturbance in
neonates experienced as a result of chronic opioid exposure in utero and withdrawal at birth
associated with irritability, poor feeding, and a high-pitch cry(Committee on Obstetric Practice &
American Society of Addiction Medicine, 2017). Women with opioid use disorder are more
likely to suffer from mental health conditions, experience poor nutrition, and to use other
substances while pregnant (Committee on Obstetric Practice & American Society of Addiction
Medicine, 2017).
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Disparities among women. Unintended pregnancy is more common among certain
groups of women. Age, relationship status, ethnicity, low income, and low education levels are
noted to be factors and are addressed under the Healthy People 2020 goal to “improve pregnancy
planning and spacing, and prevent unintended pregnancy” (ODPHP, 2014, para. 1). Barriers to
access are more likely among the same groups of women, in addition to those who are uninsured
(ODPHP, 2014).
Contraceptive barriers. Barriers to use of family planning services are multifactorial.
Cost of service, limited access to publicly-funded services or insurance coverage, lack of
awareness, transportation, clinic location, and hours are just a few noted difficulties in obtaining
care (ODPHP, 2014). Access is one of the primary barriers noted to affect a woman’s ability to
obtain contraceptive services. Insurance type and the number of visits required are important
issues to consider in offering an intrauterine device (IUD). In a retrospective analysis, fewer
women with Medicaid, when compared with women who had private insurance, received a longacting reversible contraception (LARC) method in a clinic that required two visits for insertion
(Higgins, Dougherty, Badger, & Heil, 2018). It was also noted that women with Medicaid were
more likely to become pregnant in the year following the request for LARC (Higgins et al.,
2018).
Women with SUD have unique barriers to contraceptive use that the general population
may not experience, such as a past history of sexual abuse, fear of losing their existing custodial
relationship as parents, and embarrassment regarding their substance use (Black & Day, 2016).
Interestingly, one in four women in substance use treatment reported difficulty accessing
healthcare providers, despite having consistent access to healthcare services, and reported they
would utilize family planning services if offered at their treatment program (Terplan, Lawental,
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Connah, & Martin, 2016). The perceived lack of access to healthcare services, more specifically
family planning services, may be overcome through a formal policy change for service
integration at addiction treatment centers.
Patient knowledge, or lack of knowledge, in LARC options is another potential barrier to
women with an SUD. In a survey of women receiving medication-assisted treatment, 83%
reported they were unlikely to use an IUD due to unspecified reasons and 69% due to concerns
regarding side effects. These women most commonly reported very little knowledge about
LARCs (Matusiewicz, Melbostad, & Heil, 2017). These findings suggest that the population may
benefit from further contraception education, with the potential to influence high rates of
disinterest.
Long-Acting Reversible Contraception
Long-acting reversible contraception is a category of birth control methods inclusive of
implantable and intrauterine devices. The subdermal implant and IUD are considered more
effective than all other reversible forms of contraception, such as condoms, the pill, patch, rings,
and the shot. Failure rates are less than 1% for the LARC methods (Office of Population Affairs,
2019). Higher rates of continuation and user satisfaction have been demonstrated with LARC
devices (Luchowski et al., 2014).
Safety and efficacy. Historically, there was concern regarding the safety and
appropriateness of IUD use in various groups of women. The safety of IUDs has been repeatedly
demonstrated in most women, with broadening indications for appropriateness due to proven
safety and efficacy. Age at the time of insertion, parity, and sexually transmitted infection (STI)
risk have been thoroughly evaluated in recent literature.
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Adolescent and younger women have traditionally failed to be recognized by providers as
eligible candidates for an IUD. However, there have been no demonstrated differences among
younger and older women in terms of adverse outcomes, including pregnancy, perforation,
infection, and heavy bleeding (Jatlaoui, Riley, & Curtis, 2017). Women 25 years or younger have
exhibited higher rates of expulsion, particularly with the copper (Cu) IUD (Jatlaoui et al., 2017).
This is an important consideration for healthcare providers when offering counseling and
education to younger women who request a Cu-IUD, but is not a contraindication to use.
Another safety concern regarding IUDs is the risk of genital tract infections, potentially
limiting the appropriateness of LARC methods in younger women and those at high risk for
STIs. Recent research has shown that in women with STI risk factors or with an asymptomatic
chlamydial or gonorrheal infection at the time of IUD placement were found to have no
increased risk of developing pelvic inflammatory disease when compared to other contraceptive
methods (Jatlaoui, Simmons, & Curtis, 2016). Women with SUD often have several risk factors
for STI, including multiple sexual partners, unprotected sex, intravenous drug use, age, or a
history of previous genital tract infection. This should not preclude these women as appropriate
candidates for an IUD. Chlamydia and gonorrheal testing at the time of insertion is appropriate in
those with risk factors for STIs, so that prompt treatment may occur with the IUD in place.
Another subgroup of women who were not conventionally identified as candidates for
IUDs were women who had not previously given birth. Yet, nulliparous women have not
exhibited differences in rates of infection or expulsion when compared with parous women
following IUD insertion (Foran, Butcher, Kovacs, Bateson, O’Connor, 2018). However, higher
rates of insertion failure and moderate to severe pain have been noted among women who have
not given birth (Foran et al., 2018). This is another important consideration for healthcare
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providers to consider in contraceptive counseling and during insertion appointments. Higher
levels of pain and potential insertion problems may be anticipated in women without children,
but these are still rare complications.
Best Practice Recommendations
The American College of Obstetrics and Gynecology (ACOG, 2017), in Practice Bulletin
No. 186, stated that LARC methods should be routinely recommended as a first-line
contraceptive method to women due to demonstrated efficacy and safety. Women who are
nulliparous, adolescent, or considered to be of high risk for STIs are included in the LARC
recommendation (ACOG, 2017). The ACOG also recommends that women at high risk for STIs
should undergo STI testing, but that insertion should not be delayed for test results.
The National Institute of Health and Care Excellence (NICE, 2019) revised their clinical
guidelines in 2019. They detail that even with use of a LARC method as short as 12 months, it is
still more cost effective than oral contraceptives. The guideline aims to increase uptake of LARC
methods through contraceptive counseling and education. In the recommendation, it is noted that
increasing the utilization of LARC reduces the rate of unintended pregnancies (NICE, 2019).
The Centers for Disease Control and Prevention (CDC, 2014) report “Providing Quality
Family Planning Services” provides evidence-based recommendations regarding contraceptive
services. Recommendations include contraceptive counseling that provides information
regarding a broad range of birth control options and incorporates efficacy rates. The report
advises that substance use may be a factor in correct and consistent birth control use and should
be considered by the provider (CDC, 2014). Recommended strategies for providing
contraception include keeping different methods available on site, so they may be offered at the
time of visit, and the provider is reasonably certain that the woman is not pregnant (CDC, 2014).
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However, it is also noted that even if the provider cannot be reasonably certain, the benefits of
initiating contraception likely outweigh the risks (CDC, 2014). Some examples of criteria for
reasonable certainty include it has been less than or equal to seven days after the start of early
menses, has not had sexual intercourse since the start of last menses, or has correctly and
consistently been using contraception (CDC, 2014).
The American Academy of Pediatrics (AAP, 2014) issued recommendations for
contraceptive use in the adolescent population. The AAP recommends contraceptive counseling
based on efficacy rates, with LARC methods considered first-line in adolescents. AAP also
highlights the importance of being aware of state and federal laws regarding the disclosure of
confidential health information for minors. In the State of California, minors 12 years of age and
older may consent to birth control, except sterilization, without parental consent under the
California Family Code § 6925 (National Center for Youth Law, 2003).
Available Knowledge
Contraceptive Counseling
Typically, contraceptive counseling and services occur within the setting of obstetrics and
gynecology departments, family planning clinics, primary care, or sexual health clinics. There
continues to be poor utilization of highly effective methods of birth control, known as LARC,
among all women, and rates of unintended pregnancy remain high among women in the United
States. This public healthcare issue has been recognized by the Office of Disease Prevention and
Health Promotion and incorporated into the Healthy People 2020 initiatives. Increasing the
utilization of long-acting contraceptive methods has been the focus of multiple evidence-based
guidelines, including ACOG nationally and NICE internationally. However, according to the
NCHS (2019), use of LARC methods among women ages 19 to 44 has only slightly increased,
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from 8% to 11.3% since 2011, and continues to remain low. Effective contraceptive counseling
has been proposed to improve LARC uptake among women of reproductive age. The
effectiveness of contraceptive counseling on utilization and continuation of LARC is evaluated
in the following literature review to improve utilization of LARC methods and to decrease the
rate of unintended pregnancy among women who are at risk.
PICO Question
The population, intervention, comparison, and outcome question guiding this project is:
In women, how does implementation of comprehensive contraceptive counseling, compared
with standard care, affect rates of utilization and continuation of LARC methods?
Literature Review
Search process. A comprehensive search of the available literature was performed using
the databases Cochrane, CINAHL, and PubMed. Search terms included contraception or
contraceptive, counseling, women, long-acting reversible contraception or LARC, intrauterine
device or IUD. Limits were placed to identify the most recent and relevant literature available.
Only articles published between 2013 and 2018, including women of reproductive age, peerreviewed, and published in the English language were reviewed. Articles including the male
gender, with a sole focus on adolescents, immediately post-partum women, or post-menopausal
women were excluded. Initial yield was 37 articles. After articles were reviewed for applicability
and duplicates, 13 remained. The applicable articles were then evaluated with the Johns Hopkins
Nursing Evidence-Based Practice Research Evidence Appraisal Tool and prioritized by quality of
evidence (Dang & Dearholt, 2017). Lastly, articles selected were organized in a summary table
(see Appendix A).
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LARC uptake. A landmark study, known as the Contraception CHOICE Project,
examined the effect of reducing barriers to LARC methods, with a larger goal of reducing
unintended pregnancies (Birgisson, Zhao, Secura, Madden & Peipert, 2015). Over 9,000 women
of reproductive age received tiered contraceptive counseling to increase their knowledge and
awareness of LARC methods and were then provided free contraception of their choosing. When
barriers, including education, cost, and access, were reduced, 75% of women selected a LARC
option (Birgisson et al., 2015). Interestingly, the authors also found that women who selected a
LARC were more likely to report continuation at 12 and 24 months than those who had selected
other methods (87% versus 57%; 77% versus 44%, respectively). Birgisson et al. (2015)
demonstrated that women prefer long-acting contraception and are more likely to continue use
than with other non-LARC methods when provided contraception counseling with barrier
reduction.
After implementing a standardized provider training, Gibbs et al. (2016) explored the
effect of contraception counseling among nulliparous and adolescent women. A total of 1,500
young women ages 18 years to 25 years were enrolled in either an intervention or a control clinic
in a cluster randomized trial, with 12-month follow-up. Among the intervention group, women
were more likely to receive contraceptive counseling and were nearly twice as likely to select a
LARC than the control group (Gibbs et al., 2016). Notable findings included that nulliparous
women were less likely to receive contraceptive counseling from healthcare providers (adjusted
odds ration [aOR]=.57; 95% confidence interval [CI]: .42-.79) or select a LARC (aOR=.53; 95%
CI: .37-.75) than women who had given birth (Gibbs et al., 2016). However, when older
adolescents were compared with young adult women, they had similar rates of counseling
(aOR=.85; 95% CI: .63-1.15), LARC selection (aOR=.86; 95% CI: .64-1.17), and utilization
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(adjusted hazard ratio [aHR]=.94; 95% CI: .69-1.27). Gibbs et al.’s findings highlight the
effectiveness of contraceptive counseling on LARC selection among young women. However,
the results also suggest that parity may influence a provider’s engagement in contraceptive
counseling regarding LARC methods.
Harper et al. (2015) evaluated the influence of evidence-based training for providers
regarding counseling and IUD insertion on LARC uptake. The cluster randomized trial was
performed among 40 clinics throughout the United States and included 1,500 enrolled women
ages 18 years to 25 years. Provider training at the intervention clinics included method
knowledge, counseling, and placement, while control clinics received no training. In the
intervention group, 71% of women reported their provider discussed LARC, compared to only
39% in the control group (Harper et al., 2015). Long-acting contraception was selected by 27.9%
of women in the intervention group, compared with 16.8% in the control group (Harper et al.,
2015). Again, the results of this study support effective contraceptive counseling on increased
LARC uptake.
Continuation rates. Contraceptive counseling has also been suggested to influence rates
of IUD continuation. Reasons for discontinuation of an IUD include irregular menstrual
bleeding, cramping and pelvic pain, expulsion, systemic effects, or desired pregnancy.
Discontinuation rates were evaluated through the Contraceptive CHOICE Project. Hormonal
IUDs were noted to have 7.3% discontinuation within the first six months, compared with 8.0%
for the Cu-IUD (Grunloh, Casner, Secura, Peipert, & Madden, 2013).
Raifman, Barar, and Foster (2017) investigated the effect of counseling regarding IUD
self-removability on IUD uptake, satisfaction, and continuation. The six-month study was
divided in two phases. During the first three months, the counselor provided standard
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contraceptive counseling, with the addition of IUD self-removal counseling during the last three
months. Women who selected an IUD were then compared among the control and intervention
group for differences in the previously mentioned outcome variables. There were no significant
differences in IUD uptake, satisfaction, or discontinuation rates among women who had received
counseling that included self-removal compared with those who had not received this counseling
(Raifman et al., 2017). Yet, knowledge of self-removability was high prior to intervention in both
groups (27% control, 43% intervention). An additional finding was that one-third of women who
had considered IUD removal reported barriers to removal, such as provider discouragement and
appointment availability (Raifman et al., 2017). Self-removal is an important topic to consider in
contraceptive counseling, especially when a woman expresses concern over contraceptive
control or barriers to removal.
While satisfaction with LARC methods is higher than other methods of birth control,
with comparatively high rates of continuation, the role of intensive contraceptive counseling on
discontinuation rates was undetermined. Intensive and non-intensive counseling were evaluated
for effect on discontinuation rates of three LARCs due to bleeding problems (Modesto,
Bahamondes, & Bahamondes, 2014). Participants included 297 women who had received either
a hormonal IUD, non-hormonal IUD, or implant. No significant differences were seen in
discontinuation rates due to bleeding disturbances in women who had received intensive
counseling compared with standard counseling (Modesto et al., 2014). Premature discontinuation
of an IUD may lead a woman to choose a less effective form of birth control and increase her
risk for unintended pregnancy. Although intensive versus standard counseling did not reduce the
already low rates of discontinuation attributed to bleeding disturbances, counseling about what to
expect following LARC initiation is an important strategy to prevent premature discontinuation.
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Rationale
Conceptual Framework
The conceptual framework guiding this project is the Clinical-Community Relationships
Evaluation Roadmap. Patients, clinics/clinicians, and community resources, and their interplay in
delivering clinical preventative services, are at the center of this framework (Agency for
Healthcare Research and Quality [AHRQ], 2013). There are three didactic relationships, which
are the clinic/clinician-patient relationship, clinic/clinician-community resource relationship, and
patient-community resource relationship (AHRQ, 2013). The purpose of the roadmap is to
design and implement relationships, with the goal of providing clinical preventative services
specifically through the clinical-community relationship (AHRQ, 2013). The roadmap was
developed initially for primary care clinics to expand their linkages with community resources in
providing preventative services, but it is applicable in a broader context, as well (AHRQ, 2013).
The clinic/clinician provides accessibility of reproductive services to appropriately
identified patients. As a result, barriers to access are mitigated. The interrelationship between
clinician and patient is influenced by trust, shared decision-making, and support of patient selfmanagement (AHRQ, 2013). There are currently three healthcare providers on site, including a
medical doctor, nurse practitioner, and physician’s assistant, who are well-equipped to provide
contraceptive counseling and services. Both the clinic stakeholders and clinicians recognize the
need for women with SUD to have increased access to family planning services. Expanding on
the currently offered initial screening of contraception use, the addition of contraceptive
counseling and same-day LARC services act as both a valuable community resource and a
clinical preventative service.
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Patients in the roadmap are the clients admitted for residential or outpatient treatment.
Clients requesting medication-assisted or residential treatment require medical evaluation and
clearance in the on-site clinic, providing the prime opportunity for the incorporation of family
planning services. Patient perceptions and attitudes impact contraceptive preference and
attitudes, with the potential to affect the patient-community resource relationship (Matusiewicz
et al., 2017). Patient barriers, including limited or incorrect knowledge, are addressed through
counseling that is effective, efficacy-centered, and respective of patient autonomy.
The relationship between clinic and community resource is traditionally affected by a
referral process, collaboration among providers, and feedback mechanisms between the two site
entities (AHRQ, 2013). Due to the incorporation of the community resource within the clinic,
referral processes and collaboration between external entities for the services are limited. The
framework was utilized to develop a project intervention to enhance the delivery of a clinical
preventative resource by the existing providers on site due to the rural location and lack of
outside community resources.
The project intervention included a LARC training workshop for providers, with
evidence-based clinical practice recommendations on LARC methods and a skills portion for
IUD and implant procedures. The aim of the intervention was to enhance the providers’
knowledge and procedural skills for LARC counseling and initiation in preparation for offering
services on site. Provider training was selected to target the relationship between provider and
client to increase uptake of LARC utilization through contraceptive counseling. Multiple studies
have demonstrated LARC barrier reduction, including contraceptive counseling, to increase
LARC uptake among women with underutilization (Birgisson et al., 2015; Gibbs et al., 2016;
Harper et al., 2015).
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The integration of contraceptive services within an addiction medicine center highlights
the need for effective relationships among patients, clinic/clinicians, and community resources in
addressing high rates of unintended pregnancy. This DNP project utilized the ClinicalCommunity Relationships Evaluation Roadmap to identify and address a crucial clinical
preventative service lacking for women with SUD. Barriers to patients and providers were
considered in the design of this project to improve the key didactic relationships among the
clinic/clinician, community resource, and the patient. An intervention to improve the key didactic
relationships was implemented through a LARC provider training workshop to enhance provider
knowledge and skill in providing contraceptive services. Outcome evaluation was assessed
through a pre/post assessment on provider confidence and readiness for providing contraceptive
services at the clinic. With increased confidence in LARC knowledge and procedural skill, the
providers will be adequately prepared to enhance utilization of LARC methods on site.
AIM Statement
The primary aim of this quality improvement project is to reduce rates of unintended
pregnancy among women with SUD through the development of a pilot project to integrate
contraceptive services in addiction medicine treatment. Emphasis was placed on effective
contraceptive counseling to increase uptake of highly-effective contraceptive methods.
Project Goals
1. Research and design a pilot program for the delivery of contraceptive counseling and
LARC services at Granite Wellness Centers.
2. Plan for a future pilot program rollout of contraceptive services at Granite Wellness
Centers.
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Project Objectives
1. Conduct a feasibility analysis, to include an evaluation of the current literature
regarding contraceptive counseling methods on LARC uptake and continuation;
perform a site evaluation to determine resource readiness; conduct a women’s focus
group to assess current attitudes, beliefs, and needs regarding contraception; and
identify two possible funding sources for pilot initiation.
2. Design and provide an interdisciplinary LARC training workshop for the medical
staff at Granite Wellness Centers to enhance readiness for service integration.
3. Present all findings of the feasibility study to the board members at Granite Wellness
Centers. The presentation will include recommendations for contraceptive services
derived from the feasibility analysis, a proposed timeline for implementation when
funding is obtained, and a financial analysis including a proposed budget and return
on investment.

LARC APPROPRIATENESS IN SUBSTANCE USE TREATMENT

23

Section III: Methods
Context
There is an unmet need to enhance access of contraceptive services to women with an
SUD. Offering contraceptive services concurrently with substance use treatment, with same-day
services, provides the greatest opportunity to eliminate potential barriers to contraceptive use.
Ultimately, birth control methods, known as LARC, are ideal for this patient population due to
the highest rates of efficacy among all birth control options.
The selected site for this DNP project is Granite Wellness Centers, a non-profit in the city
of Grass Valley. The clinic is located in a rural area of northern California. The stated mission
includes, “to provide a full spectrum of programs focused on reducing the social, health, and
financial impact on our families and children from all types of drug abuse” (Granite Wellness
Centers, 2019, para. 2). The site provides comprehensive addiction treatment services, including
residential, outpatient, and medication-assisted treatment. Presently, contraceptive services are
not offered on site, and patients are referred out to their primary care provider or other
community resource for healthcare needs outside of substance use treatment (see Appendix B.
Gap Analysis).
While contraceptive services are largely covered by private and public insurance
providers, the clinic site is not currently contracted for billing and reimbursement for medical
services outside of substance use treatment. The clinic was actively in the process of expanding
services provided on campus. Therefore, it was mutually agreed upon by the site stakeholders
that priority should first be placed on conducting a feasibility analysis, and a letter of support
was issued by the organization (see Appendix C). The goal of the feasibility evaluation was to
determine readiness for the integration of LARC services in preparation for a future pilot project,
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when services and related costs are covered or a funding source is available. In addition to the
feasibility analysis, this DNP student designed and executed an interdisciplinary LARC training
workshop. The training was conducted in part by IUD and implant device representatives to
provide hands-on skills training for the medical providers and education about their respective
products. The pharmaceutical representatives provided their time and training at no cost.
GANTT
The timeline of this DNP project is detailed through the use of a GANTT chart (see
Appendix D). This DNP project occurred over an 11-month period from February 2019 until
December of 2019. Following the conceptual phase and project approval was the design phase.
Details of the design phase included design of the surveys for the current client focus group,
provider training pre- and post-engagement assessment, and staff readiness for change survey,
which occurred in August and September of 2019. The women’s focus group and site assessment
were then conducted, while funding sources and other resources were explored. The main
intervention included the two-part provider LARC workshop offered in November and
December of 2019. A final presentation was prepared and delivered to the board members at
Granite Wellness Centers, including a summary of findings and recommendations for a pilot
project. Lastly, the project evaluation was closed with the final report preparation. Further project
details were organized in a work breakdown structure and communication matrix (see Appendix
E and Appendix F).
Strengths, Weaknesses, Opportunities, Threats
The strengths, weaknesses, opportunities, and threats of this project were acknowledged
to aid in the identification of potential external and internal influences (see Appendix G).
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Strengths. The internal strengths of this project include the on-site medical clinic with
patient rooms. The clinic has two patient rooms available for providers to offer contraceptive
counseling and services during medical appointments. There are three providers on site with
prior experience in IUD insertion. Also, the mission of Granite Wellness Centers is in line with
the aim of this project to reduce healthcare disparities among women with SUD. Lastly, the staff
are regularly engaged in process improvement meetings and aware of organizational change.
Weaknesses. There are also internal weaknesses to this project. An initial pilot project
requires a funding source or internal medical billing changes at the clinic, which involves
continued communication with the billing department and a search for potential funding
opportunities. Also, co-occurring service expansion places additional strain on the clinic and its
resources, with the potential to halt pilot initiation until the other service expansions are
completed. Potential weaknesses that will require continued evaluation are the upfront supply
cost and time factors related to same-day contraceptive initiation. The healthcare providers are
responsible for all residential admissions, overseeing group medication-assisted treatment
meetings and requested appointments from both residential and medication-assisted treatment
clients. Issues and appointments related to substance use will be prioritized and may affect the
ability to deliver LARC services when requested.
Opportunities. This quality improvement project provides anticipated external benefit,
as well. The first potential opportunity is the ability to reduce rates of unintended pregnancy
among women seeking substance use treatment. Adverse maternal and fetal outcomes associated
with unplanned pregnancy will also be reduced. There is an additional opportunity for women to
receive comprehensive, evidence-based contraceptive counseling. Women utilizing LARC
methods have higher satisfaction with method choice and greater control over family planning
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due to the highest efficacy rates. With success of the pilot initiation of integrated services at the
Grass Valley campus, expanded services may be added to other campuses in northern California.
Threats. The potential inability to obtain external reimbursement for services rendered is
the largest threat, as the clinic is not currently set up to bill for medical services outside of
substance use treatment. If medical reimbursement is obtained, another external threat is the
repeal of the Affordable Care Act. The Affordable Care Act is responsible for expanding
coverage of contraceptive services to patients without cost-sharing. The cost of an IUD alone is
substantial and can range from $400 to $700, which would be prohibitive to patients without
coverage. Another external threat is the development of other clinics or sites offering competing
services, with the potential to reduce client acquisition at the site.
Cost-Benefit Analysis
The proposed budget for the pilot rollout is detailed here for a three-month estimate.
Operational expenses of this project include employee salary and benefits, medical supply costs,
and laboratory testing supplies and fees. Contraceptive services are largely reimbursable through
changes made by the Affordable Care Act, ensuring coverage for contraceptive services without
cost-sharing to individuals. Supply costs for IUD insertion include a speculum, lubricant,
tenaculum, antiseptic, uterine sound, scissors, sterile gloves, ring forceps, gauze, cotton swabs,
chucks, sanitary napkins, and sterile drapes (University of California San Francisco, Bixby
Center for Global Reproductive Health [UCSF], 2015). The average IUD cost is $629.75 when
purchased from the manufacturer and disposable insertion kit price is $44.21 (UCSF, 2015).
Training time (2.5 hours to 3 hours) and provider time to complete screening, education,
documentation, insertion, and follow-up are estimated to be at a minimum 60 minutes per patient
($51.15 hourly). Laboratory testing for basic STI screening is $55 and $1.60 per test for urine
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pregnancy testing. Performing pelvic examination and IUD insertion also requires specialized
equipment. Fixed asset purchases include stirrups ($1,395) and an illumination system ($299).
Total costs expected over a three-month pilot project, including the operational and fixed asset
costs for 15 patients, are $17,390. However, as previously mentioned, these services are
reimbursable. Reimbursement may be obtained for the IUD and other supply costs, insertion,
surveillance, and an evaluation and management visit for time spent counseling patients (UCSF,
2015).
Due to the high rate and commensurately high costs associated with unintended
pregnancy, there has been a large national initiative to improve the reimbursement rates of LARC
methods. The majority of clients receiving care at Granite Wellness Centers have state-funded
insurance through the Medi-Cal Program. Reimbursement rates currently listed on the
Department of Healthcare Services(2019) site are itemized as $166.20 for insertion, $808.50 for
the Cu-IUD and $953.51 for the five-year levonorgestrel-containing IUD, a $12 dispensing fee,
$57.20 for contraceptive counseling encounter and follow-up encounter, $31.17 for each
chlamydia and gonorrhea testing, and $2.80 for a urine pregnancy test.
Return on Investment
A return on investment (ROI) is traditionally calculated by dividing the net projected
benefit by total program cost and then multiplying by 100. Upon pilot initiation, finalized
program costs can be appreciated and included in the ultimate calculations. Projected benefit
with initiation of contraceptive services is considered in the avoidance of unintended pregnancy.
Current cost avoidance estimates, including prenatal care, birth, and the first year of life care, are
$12,770 (Sonfeld & Kost, 2015). Additional costs, including medical treatment for unintended
pregnancy-related adverse outcomes in women with SUD, should also be considered. The
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average cost for the Cu-IUD and hormonal IUDs are $1,136.84 and $995.02, respectively. For
each dollar spent on IUD services, there is an expected $5 cost savings for the Cu-IUD and $4.89
for the hormonal IUD (Foster et al., 2013). Therefore, for each woman who receives an IUD for
contraception, there is an expected cost savings of $5,330. Cost savings can be achieved with the
prevention of one unintended pregnancy (see Appendix H).
Interventions
Feasibility Analysis
A feasibility analysis was conducted to determine site preparedness for a contraceptive
service integration pilot project. Components of the feasibility analysis included a site survey to
develop a comprehensive inventory list and identification of additional supplies required, a
women’s focus group exploring current attitudes to contraception, staff readiness for change
survey, and identification of possible funding sources. In preparation for the anticipated pilot
project, necessary resource documents were identified and used with permission from the
Reproductive Health Access Project to cover the establishment of new policies and procedures
(see Appendix I), consent forms, billing resources, documentation aids, supply lists, and patient
education materials (see Appendix J).
Site survey. The site survey was performed utilizing the site readiness checklist
(Reproductive Health Access Project, n.d.; see Appendix K). Issues and requirements assessed
included considerations for the facility and administrative and clinical areas. The site presently
met the facility requirements for storage space for devices, sterile equipment and non-sterile
equipment, and sterilization of equipment using an autoclave. It was noted that a policy and
procedure was not currently established for the use of the autoclave, but one was being
developed. Administrative considerations included chart note templates for IUD insertion and
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removal, up-to-date billing and coding codes, system appointment for scheduling, and system for
ordering and tracking supplies. The site had two active medical supply vendors with the
capability to order LARC supplies. Clinical considerations met were the establishment of an IUD
protocol and procedure, consent forms, patient education materials, patient aftercare information,
and malpractice coverage. Also, a patient satisfaction survey was developed by this DNP student
to aid with quality assurance when the pilot is initiated (see Appendix L).
There were some requirements not met or completed at the time of site survey. The site
has two exam rooms with exam tables. Unfortunately, the exam tables are not height adjustable
and do not have foot holders contained within them to allow lithotomy positioning. However, the
clinic had budgeted to purchase a new exam table and were working towards obtaining one with
the aforementioned requirements. Also, the site did not have IUD insertion and removal supplies
on site. A supplies list was obtained as a reference guide for pilot initiation. As previously
mentioned, billing practices were not established for medical services.
Women’s focus group. Current female clients of Granite Wellness Centers were included
in a focus group on contraception and participated in a survey of current attitudes, knowledge,
and concerns regarding contraception. This DNP student provided a comprehensive, efficacybased, contraceptive educational session, with time allowed for additional questions. Each birth
control method was briefly reviewed, starting with LARC methods and ending with the least
effective methods. Side effects, adverse effects, mechanism of action, and efficacy were
discussed. A paper survey was administered to each participant to collect additional information,
including barriers to contraception, concerns regarding birth control, existing knowledge, and
interests and concerns regarding the addition of family planning services within substance use
treatment (see Appendix M).
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Staff readiness. Staff buy-in is a vital component to organizational change. Therefore, an
intervention to assess staff readiness for the integration of contraceptive services on site was
utilized to make appropriate recommendations to the board committee. A staff survey was
designed to address the five major organizational components of change, including the need for
change, leadership and management, attitudes to change, communication, and preparation for
change (see Appendix N).
Funding sources. Funding sources were explored through a grant database search.
Grants were evaluated for applicability and appropriateness of the pilot project to meet the listed
grant criteria. Grant organizers were contacted when additional information was required.
Contraceptive services met the criteria of multiple open grants; however, they did not have an
open application cycle at the time the research was conducted. Also, the process for medical
contracting was actively pursued by the organization. The practice manager submitted a
contractual application in September 2019. In anticipation of future medical reimbursement,
billing and reimbursement were further investigated through a cost-benefit analysis and
estimated ROI.
LARC Interdisciplinary Training Workshop
A staff training course was created to provide the healthcare providers and medical staff a
review of current best practice recommendations regarding LARC utilization, skills on IUD
insertion with vaginal simulators, contraceptive counseling, and Nexplanon training and
certification. This DNP student coordinated with the representatives of Bayer, CooperSurgical,
and Nexplanon to provide a hands-on component to the workshop for skill practice and
development. The training was provided on two separate dates due to clinical providers’ time
constraints and the availability of the representatives.
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The first training date was provided by this DNP student and a Bayer representative. The
Bayer representative included an overview of their available levonorgestrel-containing devices
(i.e., Mirena, Skyla, and Kyleena), with a combined skills portion on vaginal simulators for IUD
insertion. The Bayer representative provided patient clinical education resources, noted the
ability to stock devices without upfront costs to the clinic, and the ability to obtain replacement
devices without additional cost if insertion failure occurs. This student presented evidence-based
practice recommendations regarding LARC use, safety and efficacy, and contraceptive
counseling through a PowerPoint presentation (see Appendix O). This DNP student also
provided a folder containing applicable resources for each attendant that included a billing codes
tool, birth control efficacy chart, IUD insertion and removal note templates, IUD consent form,
an IUD patient take-home sheet, and copy of presentation slides (see Appendix P). All medical
staff discussed and identified their role in enhancing contraceptive awareness through
contraceptive counseling. The nursing staff recognized opportunities to provide and reinforce
patient teaching within the residential treatment center. Additional topics discussed were
consequences of unintended pregnancy and barriers to contraceptive use in the general
population, as well as in women with SUD. A pre- and post-test were utilized to assess provider
confidence and readiness in providing contraceptive counseling and IUD insertion with the
Bayer products (see Appendix Q).
The second training date was conducted by a representative from Nexplanon on the
subdermal implant. The Nexplanon representative offered a two-hour training course regarding
the subdermal implant and removal procedure. Upon completion, the providers were given a
certification for Nexplanon insertion and removal. A pre- and post-test were utilized to assess
provider confidence and readiness in providing the Nexplanon device. Upon completion of the
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training, a training evaluation form was administered to each participant to gather information
regarding participant satisfaction and training quality and relevance (see Appendix R). Practice
kits, including an arm simulator and two implant injectors, were also given to the healthcare
providers to keep for additional practice following the training.
Presentation
The project culminated with a presentation to the board members at Granite Wellness
Centers. The final presentation included recommendations for contraceptive services derived
from the feasibility analysis, a proposed timeline for project implementation when funding is
obtained or billing practices are established, and a financial analysis including a proposed budget
and ROI. Data obtained from the women’s focus group, staff readiness for change survey, and
provider training were included in the project recommendations.
Study of the Methods
The long-term goal of this project is to prevent unintended pregnancy through the
addition of contraceptive services within substance use treatment, emphasizing LARC methods.
However, due to the current inability to bill for medical reimbursement at the clinic location,
short-term outcomes were established to prepare the clinic for future pilot initiation. The shortterm goals established to evaluate this quality improvement project were to conduct a feasibility
analysis of the site, develop an interdisciplinary LARC training workshop, and to present
findings of the feasibility analysis to the board committee in preparation for future pilot
initiation. Surveys were administered to the women at the focus group, providers pre/post the
LARC training workshop, and medical staff to determine readiness for change. Survey data were
collected and analyzed with Microsoft Excel analysis tools and Survey Monkey. All data
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collected were used to summarize findings and make appropriate recommendations for pilot
program initiation to the board members.
Measures and Methods of Evaluation
For this project, outcome measures were completing the components of the feasibility
analysis, LARC interdisciplinary training workshop, and final presentation with
recommendations for pilot project.
The feasibility analysis included a literature review, site assessment, women’s focus
group, staff readiness for change survey, and funding source identification. A survey of the
clients attending the women’s focus group was administered to gather more information from the
current clients regarding contraceptive use, attitudes, and knowledge to include in the board
committee presentation. The women’s focus group survey included three open-ended questions
and four multiple choice items. Questions included: 1. What barriers do you experience in
obtaining birth control/contraceptive services? 2. What are your concerns regarding birth
control? 3. What community organizations are you aware of that provide free/low cost birth
control? 4. What resources regarding contraceptive care would benefit you the most? 5. Would
you utilize birth control if offered at no cost while receiving treatment? 6. Have you ever
received comprehensive contraceptive counseling regarding all birth control options available to
you? 7. Which birth control options would you be most interested in receiving?
The staff readiness for change survey was administered to all medical staff following the
LARC training workshop. Readiness was assessed through agreement in responses to 16
statements corresponding to different areas of organization change. Likert-type responses ranged
from 1 for strongly disagree to 5 for strongly agree. Statements were as follows: 1. There is need
for organizational change to expand services to include contraceptive services. 2. I am aware of
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the reasons why change is needed within the organization. 3. Expanding the services provided to
the clients is appropriate and achievable. 4. I am aware that the organization is considering
expanding services offered to include contraceptive services. 5. I understand the need to include
contraceptive services in the services offered in all clinical visits including intake appointments
and follow-ups. 6. Management is committed to providing support to staff during periods of
change. 7. I am able to discuss changes with leadership and management. 8. Providing
contraceptive services will benefit the organization. 9. I am supportive of the integration of
contraceptive services into clinic appointments. 10. I know how my role can help make the
expanded services successful. 11. There is adequate consultation with staff when change occurs.
12. Staff communication is reliable and well-timed. 13. I am adequately trained to offer
contraceptive services within my role and scope of practice. 14. I have the resources I need to
provide contraceptive services within my role. 15. I am confident in my ability to provide
contraceptive services to all clientele. 16. Overall, I believe contraceptive services will be
advantageous for the clientele participating in substance use treatment and the larger community.
The interdisciplinary LARC training workshop was designed to enhance readiness and
confidence for providing contraceptive counseling and LARC procedures among medical staff.
The outcome of the LARC training workshop was assessed through an identical pre- and postengagement survey administered to the healthcare providers. Readiness and confidence
regarding contraceptive counseling and IUD insertion were measured through an eight-item
assessment, based on a 5-point Likert scale. Possible responses assessed agreement with posed
confidence and readiness statements and included: strongly agree (5), agree (4), neutral (3),
disagree (2), and strongly disagree (1). There was also a comment section included at the end of
each survey to obtain additional information from participants. Outcomes for the LARC provider
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workshop were evaluated based on the following statements: 1. I am comfortable providing
comprehensive contraceptive counseling consistent with current practice recommendations. 2. I
am confident in identifying all LARC eligible candidates. 3. I feel prepared to counsel patients
about LARC effectiveness and safety. 4. I feel confident in counseling patients about LARC
insertion and follow-up. 5. I feel comfortable with IUD insertion. 6. I am adequately prepared to
insert an IUD. 7. I have sufficient previous experience with IUD insertion. 8. Hands-on skills
training is an effective method to prepare for IUD insertion.
The outcome of the second LARC training workshop was similarly assessed through an
identical pre- and post-engagement survey administered to the healthcare providers. Readiness
and confidence regarding Nexplanon counseling, insertion, and removal were assessed through a
four-item assessment, based on a 5-point Likert scale. Possible responses assessed agreement
with posed confidence and readiness statements and ranged from strongly agree (5) to strongly
disagree (1) with additional comment section at the end. Outcomes for the second LARC
provider workshop were evaluated based on the following statements: 1. I feel comfortable with
Nexplanon insertion and removal. 2. I am adequately prepared to provide Nexplanon counseling,
insertion, and removal. 3. I have sufficient previous experience with providing the subdermal
implant. 4. Hands-on skills training is an effective method to prepare for Nexplanon insertion
and removal.
Methods for assuring data quality and accuracy included a post-training follow-up survey
with statements about training relevance, effectiveness, satisfaction, and quality. The first section
assessed satisfaction with different aspects of the training. Likert scale responses were very
satisfied (5), satisfied (4), neutral (3), dissatisfied (2), and very dissatisfied (1). Possible Likert
scale responses to posed statements regarding training content, relevance, organization, quality,
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and time included: strongly agree (5), agree (4), neutral (3), disagree (2), and strongly disagree
(1). A comments section was also available for additional information.
Analysis
The women’s focus group data were analyzed utilizing Survey Monkey. Paper surveys
were disseminated to all women in attendance. The women’s focus group survey responses were
manually entered into SurveyMonkey for analysis. Summary statistics, including frequencies and
means, were calculated. Responses to open-ended questions were ranked categorically for
similarity, with subsequent ranking by frequency. Select all that apply formatted questions were
categorized by frequency of response. Mean responses were calculated for questions with one
answer selection.
For evaluation of the LARC training workshop, qualitative data were collected through a
pre- and post-assessment survey for both training sessions. The Likert scale responses were
numerically categorized ranging from strongly disagree (1) to strongly agree (5). The responses
assessed agreement with confidence and readiness-based questions surrounding contraceptive
counseling and LARC utilization. Responses were manually entered into Excel, where the mean
response was calculated for each of the seven questions on the pre- and post-surveys. The mean
percent change (delta Δ) was calculated between the pre- and post-assessment responses to
measure the impact of the LARC workshop for medical providers. A post-training evaluation was
administered to all staff to evaluate training content, relevance, and delivery.
The staff readiness for change survey was administered at the LARC workshop to the
medical staff. The survey consisted of 16 statements, with Likert scale responses ranging from
strongly agree (5) to strongly disagree (1). The responses assessed agreement with posed
statements assessing different aspects of the change process as related to this quality
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improvement project. Survey responses were manually entered into Excel. Summary statistics
including the mean (M) and standard deviation (SD) were calculated for each statement.
Ethical Considerations
The University of San Francisco DNP department determined that this project met the
criteria for an evidence-based practice change project, as outlined in the DNP project checklist,
and was approved as non-research (see Appendix S). The primary Jesuit value of Men and
women for and with others is represented in this project. The project intends to expand currently
offered services to women in substance use treatment. This project identified a critical healthcare
disparity, with a goal to work with the current client population to reduce healthcare disparities
and barriers to care.
Ethical principles considered in this project include beneficence and respect for
autonomy. Beneficence refers to promoting the patient’s wellbeing. The goal of this project is to
help motivate patients to take control of their reproductive health and engage in contraceptive
planning. There is an increased risk of poor maternal outcomes associated with unplanned
pregnancies. Medical providers in addiction medicine are primed for the opportunity to address
contraceptive use when contact is frequent and closely monitored. Respect for autonomy is also
imperative in this project. It is essential for the client to make her own informed decision when
participating in birth control selection, once provided with all available options and information.
It is the provider’s responsibility to provide comprehensive contraceptive counseling free from
any potential bias and to respect the choice of the client.
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Section IV: Results
Qualitative data were collected through surveys disseminated at the women’s focus group
and LARC provider training workshop. The results from the surveys are discussed in detail here.
Women’s Focus Group
The women’s focus group was a 60-minute session held in the residential treatment
program building at Granite Wellness Centers in September 2019. All women in attendance were
participating in inpatient substance use treatment. Only 10 of the 13 participants completed
surveys, and it was noted that three of the women were post-menopausal. Regarding barriers to
obtaining contraception, interestingly, six of 10 respondents did not feel they currently had any
barriers, noting, “none,” “N/A,” and “none at this time.” The most common contraception
concerns were identified by participants from a select all that apply question, which included
side effects, fertility, access, ease of use, hormones, bleeding patterns, cost, effectiveness, and
other. Most commonly selected were side effects (7/10), hormones (4/10) and access (3/10). Ease
of use, bleeding patterns, and cost were less frequently reported concerns. All respondents had
knowledge of an existing community resource that offered contraception for free or at a reduced
cost. Interestingly, the community resource identified by nine of the 10 participants was Planned
Parenthood, but the nearest available clinics were approximately one hour away. When asked
what resources regarding contraceptive services would be most beneficial, respondents most
commonly selected STI testing (3/10) and free birth control (3/10). Nine of the 10 participants
reported they would utilize birth control if offered at no cost while receiving substance use
treatment. An unexpected finding was that six of the 10 women reported they had never
previously received comprehensive contraceptive counseling regarding all birth control options,
one respondent was unsure, while the remaining three respondents reported they had received
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contraceptive counseling. Lastly, the women reported which birth control options they would be
most interested in receiving from a select all that apply question, with the hormonal IUD, nonhormonal IUD, emergency contraception, condoms, birth control pills, Depo-Provera shot,
Nexplanon (implant), and other listed. The non-hormonal IUD was selected most often (5/10),
followed by condoms (3/10), hormonal IUD (2/10), and birth control pills (2/10).
LARC Training Workshop
Part 1
Two providers (physician’s assistant and family nurse practitioner) of the three medical
providers at the site attended the LARC training workshop with hands-on skills training. Both
participants had previous experience with IUD insertion. Results of the pre and post mean data
are displayed in Table 1.
Table 1
Survey Results
Survey
Pre-Survey Mean
Post-Survey Mean
% Change

S1
S2
S3
S4
S5
S6
S7
S8
3.0
3.0
2.5
3.0
2.5
2.5
3.0
3.5
4.5
4.5
4.5
4.5
4.0
4.0
3.5
4.5
33.33 33.33 44.44 33.33 37.50 37.50 14.20 22.22

Note. S denotes survey statement number.

There was a 33.33% increase in provider comfort with providing contraceptive
counseling, confidence in identifying LARC eligible candidates, and confidence in counseling
clients about the LARC insertion procedure and follow-up. Statement 3 showed the greatest
improvement, with a 44.44% increase in provider preparedness in providing counseling
regarding LARC safety and efficacy. Both providers stated they agreed with statements of
feeling comfortable and prepared for IUD insertion following training, with a 37.5% increase.
Provider attitude on whether hands-on skills training was an effective method to prepare for the
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procedure increased 22.22% following the training. No additional comments were given on the
assessments.
Part 2
Four providers attended the LARC training workshop with hands-on skills training. Two
providers were from outside clinics and medical settings. It was noted that one attendee had
previously been certified in Nexplanon insertion in 2014 and was attending the training as a
training update and refresher. Results of the pre and post mean data are displayed in Table 2.
Table 2
Survey Results
Survey
Pre-Survey Mean
Post-Survey Mean
% Change

S1
S2
2.0
3.5
4.75 4.75
57.89 26.31

S3
3.0
4.0
25.0

S4
3.75
5.0
25.0

Note. S denotes survey statement number.

The greatest increase was exhibited in provider comfortability with Nexplanon insertion
and removal post training. Statement 2 reflected a 26.31% increase in provider preparedness to
provide Nexplanon specific counseling, insertion, and removal. Provider attitude on whether
hands-on skills training was an effective method to prepare for the procedure increased 25.0%
following the training. There was similarly a 25.0% increase in agreement with the posed
statement, “I have sufficient previous experience with providing the subdermal implant”. No
additional comments were given on the assessments. Inferential analysis was not conducted due
to limitations from the small sample sizes.
Readiness for Change Survey
Ancillary medical staff attended the in-service, including the practice manager, two
medical assistants, one licensed vocational nurse, and one registered nurse. Following the

LARC APPROPRIATENESS IN SUBSTANCE USE TREATMENT

41

training, all medical staff were administered a survey to assess readiness for change. Ratings
from the staff members are displayed in Figure 1.

Figure 1. Staff readiness for changes results.
Statements 1, 2, 3, 4, and 5 assessed staff recognition for the need for change to integrate
contraceptive services within the organization, with largely favorable responses in agreement or
strong agreement. Statements 8, 9, 10 and 16 had the most favorable responses (M = 4.6, SD =
0.55), indicating strong agreement in the area of attitude to change and client benefit from the
addition of services. Responses to Statement 7 and Statement 8 pertained to leadership and
management in the change process, with responses ranging from neutral to strongly agree (M =
3.8, SD = 0.84; M = 4.6, SD = 0.55, respectively). The lowest rated responses occurred in
Statement 11 through Statement 15; these statements related to areas for communication and
preparation for change, which averaged between neutral and agree (3.0 – 3.3). Statement 13 had
the least agreement (M = 3.0, SD = 0.71), representing a neutral response to the statement, “I am
adequately trained to offer contraceptive services within my role and scope of practice.” One
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additional comment was provided from a respondent, stating, “Communication between staff can
be improved.”
LARC Training Evaluation
Four attendees completed the LARC training evaluation following the second training
session. One of the providers attended both trainings. All providers rated training satisfaction as
very satisfied regarding overall training quality, quality of instruction, training materials, and the
training experience. Providers rated strong agreement with all statements regarding training
organization, job applicability, instructor knowledge and preparedness, benefit and utilization of
training, and appropriate training length. One additional comment stated, “Great experience”.

LARC APPROPRIATENESS IN SUBSTANCE USE TREATMENT

43

Section V: Discussion
Summary
The aim of this project was to design and prepare for a pilot project for initiation of
contraceptive services at an addiction treatment center, with a larger goal of reducing rates of
unintended pregnancy. Advanced practice providers (APP) in the community recovery setting are
provided a prime opportunity to address reproductive health needs, to assess current barriers to
effective contraceptive use, and to integrate contraceptive services within substance use
treatment. The APP can identify any potential knowledge gaps and provide appropriate education
regarding the available methods of birth control and their respective efficacies. Further, offering
contraceptive services is within the scope of APP practice.
In preparation for anticipated service expansion, data were collected from current clients,
healthcare providers, and medical staff for future pilot rollout of contraceptive services at the
addiction treatment center. Key findings included feedback from current clients demonstrating
the need and interest in contraceptive services, as well as the lack of prior comprehensive
contraceptive counseling in the past. The most common client concerns cited regarding birth
control methods were related to side effects and hormones. Regarding the healthcare providers
readiness to offer contraception, respondents indicated they felt more prepared and confident to
engage in contraceptive counseling that includes LARC safety and efficacy and more confident
to perform IUD and Nexplanon insertion and removal procedures. Lastly, the medical staff
indicated largely positive responses in terms of need for change, attitude for change, and
leadership and management’s role in the change process. However, the mean response was
neutral, not in disagreement nor agreement, with being prepared to offer such services within
their scope of practice.
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Interpretation
The expected outcomes of this project included an improvement in provider confidence
and readiness with contraceptive counseling and LARC procedures following the training
intervention. Research has shown that following additional training, providers have demonstrated
increased efficacy-based contraceptive counseling that includes LARC methods (Birgisson et al.,
2015; Gibbs et al., 2016; Harper et al., 2015). Findings of this LARC training intervention were
consistent with previous research results.
Results from the client survey in the women’s focus group showed a great interest and
demand in the possibility of receiving contraceptive services within the substance use treatment
program. Ninety percent of the women who completed surveys reported they would like to
receive expanded services to include birth control services and STI testing, indicating
consequences of unprotected sex is a concern. This number was higher than expected and
perhaps represented the impact of the contraceptive counseling provided by this DNP student
within the focus group. Approximately 50% of respondents reported interest in receiving the
non-hormonal Cu-IUD, which was consistent with their most commonly reported concerns about
side effects and hormones.
Additional outcomes included the completion of the feasibility analysis, with subsequent
presentation to site board members. Based on the overall responses from the medical staff, there
was confirmed interest in expanding services to include contraceptive services. The results from
the staff readiness for change survey were largely favorable, but indicated areas for improvement
within the organization, such as staff communication and further instruction on role development
prior to future pilot rollout. Prior to pilot initiation, this DNP student can identify additional
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training resources to prepare the ancillary medical staff with role-specific information and
communication tools.
Limitations
Limitations form the project intervention include the inability for providers who
completed the training to immediately offer contraceptive services. With a delay from training to
insertion-related procedures, provider confidence and readiness may regress. However, practice
tools for insertion were obtained from the IUD representatives to keep on site to refresh skills for
insertion and were given to each participant at the Nexplanon training. The product
representatives also provided pocket instruction tools to review the sequence of procedural steps
for IUD insertion. In addition, this DNP student created LARC training resource folders with
hard copies of all information covered during the trainings.
The main barrier to implementation of a future pilot project is the current inability to bill
for reimbursement of medical services at the project site. In order to overcome this barrier,
regular meetings were held with the medical services coordinator and practice manager to
monitor the medical reimbursement status. However, external funding resources, including grant
opportunities, were recognized as a potential way to overcome this barrier. Two grant
opportunities were identified by this DNP student in preparation for future pilot initiation, but
were not currently accepting applications. Future monitoring of an open application cycle will be
necessary to further explore grant funding. Other limitations include time availability to offer
same-day contraceptive services. While there are three providers employed by the clinic, they
have alternating schedules. Priority is placed on detox, follow-up visits, and medication-assisted
treatment patients. Identifying a routine time and or day of availability to offer LARC specific
services might be ideal to reduce the competing demands.
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Conclusions
Unintended pregnancy is a significant problem in women with SUD, with economic and
health consequences. Both LARC methods have demonstrated safety and efficacy among various
groups of women, including adolescents, nulliparous women, and those at high risk for STI
(Foran et al., 2018; Jatlaoui, Simmons, & Curtis, 2016; Jatlaoui, Riley, & Curtis, 2017). Rates of
unintended pregnancy can be greatly reduced through LARC utilization, which is considered the
most effective reversible category of birth control other than abstinence. Methods for increased
LARC uptake include efficacy-based contraceptive counseling and provider training (Birgisson
et al., 2015; Gibbs et al., 2016; Harper et al., 2015).
Providing contraceptive services with an integrated approach, coinciding with substance
use treatment, addresses barriers to access. Fragmented care and requiring multiple visits to
receive LARC methods are known critical barriers to use (Higgins et al., 2018). Therefore, sameday contraceptive services further increase the likelihood of use, while reducing the likelihood of
unintended pregnancy. Ultimately, routine offering of contraceptive services in substance use
treatment is ideal to mitigate barriers in women with SUD. Implications for future practice are
not limited to substance use treatment alone. Any healthcare practice with limited contraceptive
services may benefit from additional provider training to further reduce barriers to access of
contraception.
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Funding
There were no outside funding sources provided for this quality improvement project.
There are no conflicts of interest to disclose. The product representatives offered their time
training at no cost.
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Appendix A. Evaluation Table
Citation
Birgisson et al.
(2015)

Design/Method
Observational
cohort study
Examined the
effect of tiered
contraceptive
counseling on
LARC uptake and
continuation (with
removal of
barriers to access,
cost and
education).

Sample/Setting
9,000 women
aged 14-45 years
recruited through
convenience
sampling
St. Louis region

Major Variables
Defined
Intervention:
Tiered
contraceptive
counseling
provided by
trained counselors
based on efficacy
Contraceptive
choice provided at
no cost for 2-3
years
Outcomes:
Contraceptive
method choice and
continuation

Data Analysis

Study Findings

Limitations

Descriptive
analysis with
summary statistics

75% chose a LARC method.

Variability among
individual
counselors

Higher continuation among
LARC users compared with
non-LARC users at 12
months (87% vs. 57%) and
24 months (77% vs 41%).

No comparison
group
Services were
provided at
different sites and
clinics
Contraception was
provided at no
cost
Generalizability
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Harper et al.
(2015)

Clusterrandomized trial
Examined the
effect of
clinic/clinician
contraceptive and
insertion training
on patient LARC
selection.

40 Planned
Parenthood clinics
in the USA
Eligible women
were 18-25 years
old
2-month
recruitment
process with paid
incentives for
participation
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Intervention:
Clinic training to
improve
providers’
method-specific
knowledge and
counseling and
placement skills

Analyses through
intention to treat

Outcomes: LARC
selection and
pregnancy rates

Life-table analysis
and Kaplan-Meier
survival estimates
on pregnancy rates

Logistic
regression to
estimate
intervention effect
on LARC uptake

Women were more likely to
choose a LARC in the
intervention group,
intracluster correlation 0.05
(95 CI, 0.02 to 0.08).
Increase in the proportion of
women using LARCs in the
intervention compared to
control group (2.3% vs 2.0%,
coefficient for difference
0.0004, 95% CI 0.0030.004).
Pregnancy rates were 15 per
100-perosn years in
intervention group vs. 18.5
per 100 person-years in the
control (hazard ratio 0.89,
95% CI 0.64-1.24).

Modesto et al.
(2014)

Randomizedclinical trial 2011
to 2013
Brazil

297 women that
selected either a
98 ENG-implant,
99 LNG-IUS, or
100 TCu380A
IUD

Intervention:
Intensive
counseling at 45
days, 6 months,
and 12 months
following
insertion
Comparison:
Routine
counseling

Outcomes:
Continuation
rates, reasons for
discontinuation,
user satisfaction at
12 months

SPSS version 20
ANOVA or
Kruskal-Wallis
test
Chi-squared test

Discontinuation rates due to
expulsion were higher for the
Cu-IUD (p = 0.008), due to
weigth gain among ENGimplant (p = 0.022).
There were no significant
differences of women
discontinuing the method due
to bleeding in either group.
1-year continuation rate was
73% for Cu-IUD, 83% ENGimplant.
User satisfaction was 86%
for the Cu-IUD and 90% for
the LNG-IUS.

Outside funding
source
Variability among
providers and
clinics
Generalizability to
clinics outside of
Planned
Parenthood
Un-blinded upon
assignment of
intervention
Additional patient
education tools
provided

Standard
counseling
potentially already
adequate
Possible patient
information
sharing in waiting
room
External funding
source
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Raifman et al.
(2018)

Prospective cohort
study
Evaluated the
effect on
counseling
containing IUD
self-removal on
uptake,
satisfaction, and
continuation.

361 women who
selected IUD after
contraceptive
counseling

Intervention:
Counseling,
including IUD
self-removal

Family planning
clinics in
Michigan,
Missouri, New
Jersey, and Utah

Outcomes: IUD
uptake,
satisfaction, and
continuation
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Descriptive
analyses on effect
of study group on
adoption of the
method, method
satisfaction,
continuation,
reasons for
discontinuation
Multivariable
discrete-time
logistic survival
model on
relationship
between study
group and IUD
discontinuation

No significant difference in
IUD uptake rate by group
(control 7% [95% CI, 6.87.8]; intervention 7% [95%
ci, 6.4-7.5]).
At the New Jersey site,
uptake was higher among the
intervention group (13% vs
85; p = 0.006), but lower at
another site (12% vs. 17%; p
= 0.044).

Pre-existing
knowledge
regarding selfremoval
Confounders
related to time
differences in
recruitment for
control and
intervention group
Small sample size

There were no differences in
continuation rates by group
or state.
Control participants were
more likely to consider
discontinuation at 6 months
(15% vs 7%: p = 0.047)

Variation in sites
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Gibbs et al.
(2016)

Cluster
randomized trial
Examined the
effect of provider
LARC training on
LARC use.

1,500 sexually
active women
aged 18-25

Intervention:
Provider LARC
training

20 intervention
and 20 control
clinics

Outcomes: LARC
counseling, LARC
selection, LARC
initiation

Random
allocation to
intervention to
control groups
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Stata version 14.0
Logistic
regression
Cox proportional
hazards model

Young adults and
adolescents in the
intervention group were
more likely to select a LARC
than the control (73% vs
41%, 66% vs 33%,
respectively).

Participants aged
18-25 years only

Initiation rates were higher
among the intervention
group.

Variability among
providers and
clinics

Nulliparous women
compared with parous
women had lower rates of
LARC counseling (.57; 95%
CI: .42 - .79), lower LARC
selection (adjusted Odds
Ratio = .53; 95% CI: .37 .75), and lower LARC
initiation (adjusted Hazards
Ratio = .65; 95% CI: .48.90).

Outside funding
source
Generalizability

LARC APPROPRIATENESS IN SUBSTANCE USE TREATMENT

60

Appendix B. Gap Analysis
Gap Analysis
Project
Name

LARC Method Appropriateness in Substance Use Treatment:
A Quality Improvement Project for Integrated Care

Date
Project
Aim

May 2019
The predominant aim of this quality improvement project is to reduce rates of unintended pregnancy
among women with SUD through the development of a pilot project that integrates evidence-based
contraceptive services, emphasizing highly effective methods.
Current State
Best Practice
Proposed Solution
Unintended pregnancy rates are
estimated to be 85% among women
with a substance use disorder.

Client misperceptions regarding
LARC methods and limited
knowledge regarding side effects,
efficacy, and potential adverse
effects.

Contraceptive use screening in
medical appointments for clients
receiving inpatient and outpatient
substance use treatment.

Recommend offering a LARC
option, including:
• Same-day service when
possible
• Without delaying for the
results of STI testing with
normal examine findings and
reasonable certainty that
client is not pregnant
Recommend comprehensive
contraceptive counseling including:
• Efficacy rates
• Side effects
• Potential adverse outcomes
• Respect of patient autonomy

A feasibility analysis will be
conducted to design and develop a
pilot project rollout of the
incorporation of LARC services
within substance use treatment
appointments.

Recommend the integration of
contraceptive services within
substance use treatment.

Identify 2 possible funding sources,
including grant opportunities, for
the expansion of contraceptive
services.

Providers will be delivered a
LARC-focused training that
includes evidence-based
recommendations regarding
contraceptive counseling and
hands-on skills training.
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Appendix E. Work Breakdown Structure
1.0 Design
1.1 Develop Project Scope
1.2 Needs Assessment/Gap Analysis
1.3 Develop Objectives
1.4 Identify Key Stakeholders
1.5 Develop Project Charter
1.6 Submit Project Charter
2.0 Plan
2.1 Identify Project Team
2.2 Discussion of Roles
2.3 Develop Project Plan
2.4 Develop WBS
2.5 Develop Surveys
2.6 Prepare Staff Training Protocol
3.0 Intervention
3.1 Feasibility Analysis
3.1.1 Women’s Focus Group
3.1.2 Staff Survey
3.1.3 Site Survey
3.2 Develop Policies and Procedures
3.3 LARC Training Workshop
3.3.1 LARC Training 1
3.3.1.1 Bayer Skills Training: Mirena, Skyla, Kyleena
3.3.1.2 Best Practice Review
3.3.2 LARC Training 2
3.3.2.1 CooperSurgical Skills Training: ParaGard
3.3.2.2 Nexplanon Training & Certification
3.4 Identify Funding Sources
4.0 Results
4.1 Present Results to the Board Committee
4.1.1 Analyze Survey Findings
4.1.2 Summarize Findings and Write Recommendations
5.0 Evaluation
5.1 Identify Student for Pilot Hand-Off
5.2 Review Training Feedback
5.3 Write Final Report
5.4 Dissemination
5.4.1 DNP Paper
5.4.2 DNP Presentation
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Appendix F. Communication Matrix
Activity

Purpose

Disseminate
Project to Staff

Engage staff
member
involvement and
obtain buy-in
Gain approval
for project
implementation
Project updates,
revisions,
training, and
evaluation

Project Proposal

Staff Meetings

Responsible
Person
Project Leader

Involved
Stakeholders
Medical staff

Project Leader

Board members
and medical
director
All project
members
including
clinical site
participating
staff
Providers on
site, medical
staff, and current
clients
Board members
and clinical staff

Project Leader
Project Chair

Feasibility Study

To gather data
from appropriate
stakeholders

Project Leader

Program
Evaluation

Analysis and
dissemination of
results

All Project Team
Members
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Appendix G. SWOT Analysis
Strengths
• Promoting patient involvement in care
• Increasing access to community-based
resources
• Providing access to care
• Providing contraceptive services
• Providing patient education regarding
contraceptive methods
• Educating regarding common myths
• Pre-existing on-site medical clinic
• Two patient exam rooms
• Three experience healthcare providers on staff
• Regular staff process improvement meeting

Weaknesses
• Cost
• Inability to bill for reimbursement
• Substance use appointments will take priority
• Limited time available
• Limited providers available
• Patient misbeliefs and misperceptions

Opportunities
• To reduce rates of and prevent unintended
pregnancy
• Reduce potential adverse maternal and fetal
outcomes associated with unplanned
pregnancy
• Provide comprehensive, evidence-based
contraceptive counseling
• Increase client satisfaction in contraceptive
method choice and increase greater control
over family planning
• To perform STI screening
• To perform pregnancy screening
• Extend contraceptive services to additional
campuses within the organization

Threats
• Clinic closure
• Competing reproductive service sites
• Patient attrition
• Repeal of the Affordable Care Act
• Lack of external funding source
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Appendix H. Cost-Benefit Analysis
Costs

Fixed Asset Start-Up Expenses
Medical Equipment
Furniture
Total Fixed Asset Start-Up Expenses
Operating Expenses
Salaries and Wages (0.05 NP FTE )
Benefits at 30% of Employee’s Salary
Medical Supplies
Contracted Services
Miscellaneous Costs (Support staff,
Forms, etc.)
Total Operating Expenses
Total Costs
Revenue
Projected billable revenue through
Medi-Cal Reimbursement for
contraceptive counseling, IUD, IUD
Insertion, Dispensing Fee, Follow-up
Visit, STI Testing)
Total Gross Revenue
Net Revenue

Pilot Study Cost
(Initial 3
Months)

FY1

FY2

$299.00
$1,395.00
$1,694.00

$0
$0
$0

$0
$0
$0

$3,799.80
$1,139.94
$10,133.40
$825.00

$15,199.2
$4,559.76
$40,533.60
$3,300.00

$15,487.96
$4,646.40
$40,533.60
$3,300.00

$105

$420

$420

$16,003.14
$17,697.14

$64,012.56
$65,706.56

$64,387.96
$64,387.96

$17,490.90

$69,963.60

$69,963.60

$17,490.90
($206.24)

$69,963.60
$4,257.04

$69,963.60
$5,575.64
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Appendix L. Patient Satisfaction Survey
Patient Satisfaction Survey
Thank you for taking the time to complete this survey. Your feedback will be used to improve
the services offered.
s

Strongly
Agree

Agree Neutral Disagree Strongly
Disagree

Receiving contraceptive services
and counseling was helpful.
Contraceptive counseling was
provided by the healthcare
provider that helped me make an
informed decision.
I was provided instructions
regarding method choice and
follow-up care.
The provider gave me his or her
attention.
The provider understood and
addressed my concerns.
The provider answered my
questions clearly.
I am satisfied with my visit.
I am satisfied with the quality of
care I received.
It was easy to schedule a followup appointment.
I received the results of my lab
tests in a timely manner.
I did not have difficulty obtaining
a contraception method of my
choosing.
I would recommend the services
I received to other patients.

What can we do differently in the future to make your experience more positive?

Not
Applicable
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